ArticleFrontiers in immunology2026

Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host disease.

Christian Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.